top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Japan's Olympus names Stefan Kaufmann as next CEO in medtech pivot

gdelacruz57
Oct 26, 2022
1 min read

Tokyo, October 21. 2022 (Reuters) -- Olympus Corp (7733.T) said on Friday that Stefan Kaufmann would become the endoscope maker's chief executive next year, becoming one of the few foreigners to run a major Japanese company.

Read full article here.

Recent Posts

$150M Deal: Regeneron and Tessera Collaborate on Gene Therapy for 200,000 AATD Patients

Tarrytown, NY and Somerville, MA, December 1, 2025 (Globe Newswire) -- Regeneron Pharmaceuticals and Tessera Therapeutics are collaborating to develop TSRA-196, an in vivo Gene Writing therapy targe

Novocure Appoints Frank Leonard as CEO After 15+ Years Driving Growth

Baar, Switzerland and Portsmouth, NH, December 3, 2025 (Business Wire) -- Novocure (NASDAQ: NVCR) named Frank Leonard as its new Chief Executive Officer, effective immediately, following the resigna

Solventum to Acquire Acera Surgical for $725M Plus $125M in Milestones, Expanding into Synthetic Tissue Matrices

St. Paul, MN, November 20, 2025 (PRNewswire) -- Solventum (NYSE: SOLV) will acquire Acera Surgical, a private bioscience company specializing in fully engineered materials for regenerative wound car

Comments

Life Science Headlines

$150M Deal: Regeneron and Tessera Collaborate on Gene Therapy for 200,000 AATD Patients

Novocure Appoints Frank Leonard as CEO After 15+ Years Driving Growth

Solventum to Acquire Acera Surgical for $725M Plus $125M in Milestones, Expanding into Synthetic Tissue Matrices

Baird Medical Names Mark Saxton as CEO

$2.3B Deal: GE HealthCare to Acquire Intelerad to Boost Cloud Imaging

Hippocratic AI closes $126M Series C at $3.5B valuation

Ovid Therapeutics announces CEO transition effective January 2026

J&J to Acquire Halda Therapeutics for $3.05B

AdvanCell Names Philina Lee as New CEO to Lead U.S. Expansion

Pfizer Finalizes $7B Acquisition of Metsera to Bolster Obesity Pipeline

bottom of page